Ophthalmology

Ankur Shah, MD, discusses key highlights of his presentation titled "YUTIQ CALM: a real-world registry study of the fluocinolone acetonide intravitreal implant 0.18 mg in chronic non-infectious posterior uveitis," during ASRS 2021.

Paul Hallen discusses the Retina Industry Insights panel at the Ophthalmology Innovation Summit in San Antonio, Texas.

The FDA approved Ocular Therapeutix Inc.’s Supplemental New Drug Application (sNDA) that further extends Dextenza’s (dexamethasone ophthalmic insert) 0.4 mg indications, the company announced Monday.

During the American Society of Retina Specialists 2021 annual meeting, David Boyer, MD, told attendees that pegcetacoplan used to treat geographic atrophy proved to be well tolerated by patients in the phase 3 DERBY and OAKS studies.

During a presentation at the American Society of Retina Specialists 2021 annual meeting in San Antonio, W. Lloyd Clark, MD, presented results of the PANORAMA Study. The focus of the study, Clark said, was to identify the factors that increase the risk of complications in patients with nonproliferative diabetic retinopathy to provide information for making decisions on treatment choices.

The EIDON Ultra-Widefield Lens module from iCare USA has received 510(k) approval from the FDA for distribution in the US.

MicroPulse can reduce burden of injections for patients with diffuse diabetic macular edema.

Investigators hope to develop a novel artificial intelligence model.

In the final installment of his COVID-19 interview series, Dr. Breazzano discusses the positive lessons he's learned during the crisis.

Researchers set out to identify clinical and anatomic factor-associated vision loss in eyes with treatment-naïve DME and good initial VA.

The Association for Research in Vision and Ophthalmology recognizes their latest cohort to complete the Women Leadership Development Program.

The white cane receives assistive updates to guide visually impaired users to destinations, making indoor navigation in unfamiliar locations easier and safer.

Dr. Breazzano discusses the professional challenges and personal effects he faced during the beginning of the COVID-19 pandemic.

In PIONEER study, investigators outline successes.

John Pollack, MD, discusses gene therapy advancements in the first installment of his blog for Modern Retina.

A study in the United Arab Emirates reported a possible link between adverse ocular events and a COVID-19 vaccination.

A poll for retina specialists regarding their preference on attending specialty conferences and meetings. This poll is closed.

Investigators at Dartmouth College have found that eye contact during a conversation makes the discussion more appealing to its participants.

Dr. Breazzano discusses how clinicians can learn from the COVID-19 pandemic and prepare for future crises.

Investigators find that wearable aid offers improved mobility.

In the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.

Anterior uveitis therapy offers anti-inflammatory effect after dosing is stopped.

In a presentation at the EURETINA 2021 Virtual Conference, Tunde Peto, MD, PhD, pointed out that while complications associated with diabetes develop over a long period, ophthalmologists today have an excellent understanding of diabetes-related eye changes.

Grazia Pertile, MD, discusses the highlights of her presentations on the management of retinal folds after retinal detachment and the role of the anterior vitreous as a cause of recurrent retinal detachment.

This conference titled, “The Top Ten Things I Wish I Knew Sooner,” is the brainchild of Lisa M. Nijm, MD, JD, who has had the foresight to help young ophthalmologists negotiate the choppy waters of a new practice.

Amid a surging COVID-19 pandemic, ophthalmologists in the path of Hurricane Ida are now dealing with the storm's impact.

Dr. Jorge Calzada's diabetic macular edema blog dives into his successful treatment of DME with MicroPulse.

Investigators find imaging method may be useful to monitor disease progression.

Organization looks to improve global eye care through ophthalmic education.

Mark Breazzano, MD, discusses his views on the future of telehealth for ophthalmologists and retina specialists.